Johnson & Johnson to spin off orthopaedics division
Split of unit making knee and hip replacements comes as US healthcare group seeks shift to higher-growth areas
Split of unit making knee and hip replacements comes as US healthcare group seeks shift to higher-growth areas
Pharma group hopes acquisition will help to offset losses from expiring patents on blockbuster drugs
A former New York Times reporter accuses the US company of corporate gaslighting on an epic scale in his book ‘No More Tears’
Johnson & Johnson on Tuesday said it plans to separate its orthopedics business into a standalone company named DePuy Synthes.
Accelerating the technology’s safe adoption in hospitals should be a priority
Acquisition by private equity groups would be one of the biggest take-private deals of the year
US health and insurance company profits shrink as patient care costs surge after difficult start to 2025